Cargando…

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications

Allogeneic hematopoietic stem cell transplantation is associated with serious complications, and improvement of the overall clinical outcome of patients with hematological malignancies is necessary. During the last decades, posttransplant donor-derived adoptive cellular immunotherapeutic strategies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reis, Monica, Ogonek, Justyna, Qesari, Marsela, Borges, Nuno M., Nicholson, Lindsay, Preußner, Liane, Dickinson, Anne Mary, Wang, Xiao-nong, Weissinger, Eva M., Richter, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107577/ https://www.ncbi.nlm.nih.gov/pubmed/27895644 http://dx.doi.org/10.3389/fimmu.2016.00500

Ejemplares similares

Pathophysiology of GvHD and Other HSCT-Related Major Complications
por: Ghimire, Sakhila, et al.
Publicado: (2017)

Milestones of Hematopoietic Stem Cell Transplantation – From First Human Studies to Current Developments
por: Juric, Mateja Kralj, et al.
Publicado: (2016)

B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Juric, Mateja Kralj, et al.
Publicado: (2017)

Pulmonary Complications Associated with HSCT
por: Kapadia, Malika, et al.
Publicado: (2017)

Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Ogonek, Justyna, et al.
Publicado: (2016)

Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function
por: Reis, Monica, et al.
Publicado: (2018)

Dentistry consensus on HSCT – Part III: Special topics – Dentistry on HSCT
por: Santos, Paulo Sérgio da Silva, et al.
Publicado: (2023)

Dental consensus on HSCT – Part II: dental Care during HSCT
por: Gobbi, Marcella Ferreira, et al.
Publicado: (2023)

Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation
por: Varanasi, Pavankumar Reddy, et al.
Publicado: (2019)

Human CD8+ CD57- T(EMRA) cells: Too young to be called "old"
por: Verma, Kriti, et al.
Publicado: (2017)

Global phenotypic characterisation of human platelet lysate expanded MSCs by high-throughput flow cytometry
por: Reis, Monica, et al.
Publicado: (2018)

Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party
por: Greco, Raffaella, et al.
Publicado: (2023)

Exceptional Responder to Immunotherapy: A Rare Case of Post-HSCT DLBCL Relapse Responding to Nivolumab
por: Madabhavi, Irappa, et al.
Publicado: (2019)

Establishing the hematopoietic stem cell transplant (HSCT) in a developing country; the journey of HSCT in Semarang, Indonesia
por: Santosa, Damai, et al.
Publicado: (2020)

Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
por: Xu, Zhengli, et al.
Publicado: (2021)

Lipid Complications after Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients
por: Bis, Gabriela, et al.
Publicado: (2020)

HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response—Implications on HSCT Outcome
por: Kraemer, Thomas, et al.
Publicado: (2015)

HSCT: Therapie und Prophylaxe von Komplikationen
por: Sonnet, Miriam
Publicado: (2022)

COVID-19 Infection of HSCT Recipients Is Associated with High Mortality but No Detectable Cytokine Storm at Presentation
por: Lucchini, Giovanna, et al.
Publicado: (2021)

Herpes Simplex Virus Type 1 Infects Enteric Neurons and Triggers Gut Dysfunction via Macrophage Recruitment
por: Brun, Paola, et al.
Publicado: (2018)

Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT
por: Redjoul, Rabah, et al.
Publicado: (2021)

Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
por: Redjoul, Rabah, et al.
Publicado: (2021)

Late Complications in acute Leukemia patients following HSCT: A single center experience
por: Vaezi, Mohammad, et al.
Publicado: (2016)

PW03-021 - HSCT in mevalonate kinase deficiency
por: Wolska-Kuśnierz, B, et al.
Publicado: (2013)

Biological and Genetic Aspects of Donor-Recipient Matching in HSCT
por: Lange, Andrzej, et al.
Publicado: (2012)

Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies
por: Morris, Emma C., et al.
Publicado: (2019)

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
por: Greco, Raffaella, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients
por: Machado, Clarisse MARTINS, et al.
Publicado: (2020)

Fusarium infection manifesting as toe cellulitis in HSCT recipient
por: Malkiel, Sarah, et al.
Publicado: (2022)

COVID-19 and HSCT (Hematopoietic stem cell transplant)
por: Strasfeld, Lynne
Publicado: (2022)

Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity
por: Nicholson, Bethany, et al.
Publicado: (2022)

PB2208: CAR-T TREATMENT POST FIRST ALLO-HSCT FAILURE MAY HAVE DIFFERENT PROCESSION COMPARING TO CAR-T BEFORE ALLO-HSCT
por: wang, D., et al.
Publicado: (2022)

Oral Dysplastic Complications after HSCT: Single Case Series of Multidisciplinary Evaluation of 80 Patients
por: Leuci, Stefania, et al.
Publicado: (2020)

Continuous non-invasive monitoring of the skin temperature of HSCT recipients
por: van Vliet, Maarten, et al.
Publicado: (2009)

Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia
por: Ohmoto, Akihiro, et al.
Publicado: (2022)

The Role of Complement in HSCT-TMA: Basic Science to Clinical Practice
por: Meri, Seppo, et al.
Publicado: (2022)

Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia
por: Liu, Zenghui, et al.
Publicado: (2020)

Teaching an old dog new tricks: next-generation CAR T cells
por: Tokarew, Nicholas, et al.
Publicado: (2018)

Hospital survival following pediatric HSCT: changes in complications, ICU therapies and outcomes over 10 years
por: Olson, Taylor L., et al.
Publicado: (2023)

Cellular immunotherapies for cancer
por: Hayes, Conall
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qqhf4nr8v64136juaguthdn3e4